Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome - PubMed (original) (raw)

Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome

Benjamin D L Li et al. Ann Surg. 2002 May.

Abstract

Objective: To validate the authors' initial hypothesis-generating observation that eukaryotic initiation factor 4E (eIF4E) protein elevation predicts a higher cancer recurrence rate in patients with stage 1 to 3 breast cancer.

Summary background data: Tumor size and nodal status continue to be the two most important independent prognostic markers in breast cancer, despite well-documented limitations. In a previous smaller retrospective study, eIF4E, important in the regulation of protein synthesis of mRNAs with long or complex 5' untranslated regions, appeared promising as an independent predictor of breast cancer recurrence.

Methods: Specimens and clinical data from 191 patients with stage 1 to 3 breast cancer were accrued prospectively. Data collected include stage of disease, tumor grade, age at diagnosis, and menopausal status. Endpoints measured were disease recurrence and cancer-related death. eIF4E protein level was quantified using Western blot analysis. Immunohistochemical staining was used to determine estrogen receptor, progesterone receptor, and HER-2/neu receptor status. Statistical analysis include Cox proportional hazards model, log-rank test, Kaplan-Meier survival curve, Fisher exact test, and t test.

Results: Patients were divided into three groups based on tertile distribution of eIF4E: low, defined as less than 7.5-fold elevation (n = 64); intermediate, defined as 7.5- to 14-fold elevation (n = 61); and high, defined as more than 14-fold elevation (n = 66). The relative risk for cancer recurrence with intermediate elevation was 4.1 times that of patients with low elevation. For patients with high elevation, the relative risk for recurrence was higher, at 7.2 times that of the low group. The relative risk for cancer-related death for high elevation was 7.3 times that of patients with low eIF4E. Using multivariate analysis, high eIF4E remained an independent predictor of cancer recurrence after adjusting for tumor size, tumor grade, nodal disease, estrogen receptor status, progesterone receptor status, and menopausal status.

Conclusions: High eIF4E is an independent predictor of cancer recurrence in patients with stage 1 to 3 breast cancer. The relative risk for cancer recurrence increases with eIF4E protein elevation. High eIF4E elevation is also associated with an increased relative risk for cancer-related death.

PubMed Disclaimer

Figures

None

Figure 1. A typical Western blot showing the intensity of the 25-kd eIF4E protein band in carcinoma specimens CA1 through CA5 relative to benign control and the eIF4E standard curve.

None

Figure 2. Tertile distribution of eIF4E overexpression.

None

Figure 3. Comparison of disease-free survival using the Kaplan-Meier method between the groups of patients with low, intermediate, and high eIF4E protein elevation.

None

Figure 4. Comparison of cancer-related death rates using the Kaplan-Meier method between the groups of patients with low, intermediate, and high eIF4E protein elevation.

Similar articles

Cited by

References

    1. Weidner N, Cady B, Goodson WH III. Pathologic prognostic factors for patients with breast carcinoma: which factors are important. Surg Oncol Clin North Am 1997; 6: 415–453. - PubMed
    1. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001; 25: 767–772. - PubMed
    1. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999; 17: 2334–2340. - PubMed
    1. DeBenedetti A, Harris AL. EIF4E expression in tumors: its possible role in progression of malignancies. Int J Biochem Cell Biol 1999; 31: 59–72. - PubMed
    1. Rhoads RE, Joshi-Barve S, Rinker-Schaeffer C. Mechanism of action and regulation of protein synthesis initiation factor 4E: effects of mRNA discrimination, cellular growth rate, and oncogenesis. Prog Nucleic Acid Res Mol Biol 1993; 46: 183–219. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources